Novavax Stock (NASDAQ:NVAX), Quotes and News Summary

Q: What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.

Open	$10.020
Close	$8.880
Volume / Avg.	170.872M / 6.850M
Day Range	8.610 - 11.000
52 Wk Range	3.532 - 11.360
Market Cap	$1.251B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	87
Short Interest	40.28%
Days to Cover	11.16

Recent News

Crude Oil Down 1%; Sweetgreen Shares Spike Higher

Avi Kapoor

Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)

Editor’s note: This story has been updated to correct an error in the price action of Charter Communications stock.

Piero Cingari

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Novavax (NVAX) stock?

You can purchase shares of Novavax (NASDAQ: NVAX) through any online brokerage.

View our list of the best stock brokerages.

Who are Novavax's (NVAX) competitors?

Other companies in Novavax’s space includes: Cabaletta Bio (NASDAQ:CABA), Altimmune (NASDAQ:ALT), CareDx (NASDAQ:CDNA), Pharming (NASDAQ:PHAR) and AnaptysBio (NASDAQ:ANAB).

What is the target price for Novavax (NVAX) stock?

The latest price target for Novavax (NASDAQ: NVAX) was reported by B of A Securities on Friday, May 10, 2024. The analyst firm set a price target for 12.00 expecting NVAX to rise to within 12 months (a possible 34.68% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for Novavax (NVAX)?

The stock price for Novavax (NASDAQ: NVAX) is $8.91 last updated May 10, 2024 at 7:59 PM EDT.

Does Novavax (NVAX) pay a dividend?

There are no upcoming dividends for Novavax.

When is Novavax (NASDAQ:NVAX) reporting earnings?

Novavax’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is Novavax (NVAX) going to split?

There is no upcoming split for Novavax.

What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-